top of page
URRA CMC
no pro picture 1
no pro picture 1

22 February 2024

Drug Quality Surveillance Program

no pro picture 1

6 February 2023

ICH Q9 Quality risk management - Scientific guideline

no pro picture 1

10 July 2019

Harmonizing Compendial Standards With Drug Application Approval Using the USP Pending Monograph Process Guidance for Industry

no pro picture 1

18 November 2022

Reflection Paper on the Use of Artificial Intelligence (AI) in the Medicinal Product Lifecycle

no pro picture 1

29 October 2019

Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts With Electronics or Software Guidance for Industry

no pro picture 1

19 April 2018

Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products--Quality Considerations

The Latest

Drug Quality Surveillance Program

22 February 2024

ICH Q9 Quality risk management - Scientific guideline

6 February 2023

Harmonizing Compendial Standards With Drug Application Approval Using the USP Pending Monograph Process Guidance for Industry

10 July 2019

Reflection Paper on the Use of Artificial Intelligence (AI) in the Medicinal Product Lifecycle

18 November 2022

Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts With Electronics or Software Guidance for Industry

29 October 2019

Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products--Quality Considerations

19 April 2018

Guideline on computerised systems and electronic data in clinical trials

10 March 2023

Guideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials

31 December 2016

Providing Over-the-Counter Monograph Submissions in Electronic Format

27 September 2022

US FDA

Control of Nitrosamine Impurities in Human Drugs

General, Clinical, Procedural, Post-approval

logo apsyos

Our Address

Talk To our Experts

Email Us

We are located near Basel

Thanks for subscribing!

Apsyos

As Health is the main priority in our lives, it is important that patients get the most appropriate and safe treatments in the fastest and most reliable way without compromising of its quality.

About

​Apsyos offers small and medium pharmaceutical and biologic manufacturers the freedom to focus their internal capacities towards Science and Clinical Concerns by alleviating technical regulatory aspects.

We are operating from London and Basel

Map

©2021 par Apsyos. Créé avec Wix.com.

About Us   Services   Privacy

J2 RA CMC Services Ltd, 128 City Road EC1V 2NX, London, United Kingdom

Registered Company Nr: 16260386

bottom of page